# A Single- and Multiple-Ascending Dose Study of SRK-439 in Healthy Adults

> **NCT07444294** · PHASE1 · RECRUITING · sponsor: **Scholar Rock, Inc.** · enrollment: 76 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Placebo
- **DRUG:** SRK-439
- **DRUG:** SRK-439

## Key facts

- **NCT ID:** NCT07444294
- **Lead sponsor:** Scholar Rock, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-21
- **Primary completion:** 2026-12-17
- **Final completion:** 2027-06-09
- **Target enrollment:** 76 (ESTIMATED)
- **Last updated:** 2026-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07444294

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07444294, "A Single- and Multiple-Ascending Dose Study of SRK-439 in Healthy Adults". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT07444294. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*